Lv1
50 积分 2022-06-20 加入
Engineering a Nanoscale Al‐MOF‐Armored Antigen Carried by a “Trojan Horse”‐Like Platform for Oral Vaccination to Induce Potent and Long‐Lasting Immunity
1个月前
已完结
Paeoniflorin alleviates CKD-associated constipation by modulating TPH1/AHR-related signaling and suppressing NLRP3/GSDMD-mediated pyroptosis
1个月前
已完结
Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression
2个月前
已完结
2-year real-world clinical outcomes on the use of Faricimab in neovascular age-related macular degeneration
2个月前
已完结
Geniposide Stabilized Atherosclerosis Plaque by Induced M2 Polarization via PPARγ Signaling Pathway
2个月前
已完结
Impact of Estimated Glomerular Filtration Rate Equations on Vancomycin Dosing and Treatment Outcomes
2个月前
已完结
Impact of Sugammadex versus Neostigmine on Diaphragmatic Function and Respiratory Recovery in Morbidly Obese Patients with Moderate Neuromuscular Block: A Randomised Double-Blind Controlled Trial
2个月前
已完结
Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
3个月前
已完结
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
3个月前
已完结
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
3个月前
已完结
皖公网安备34019202002308
